Related Experiment Video
Updated: Jun 21, 2026

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
Disseminated bacille Calmette-Guérin disease in HIV-infected South African infants
A C Hesseling1, L F Johnson, H Jaspan
1Desmond Tutu TB Centre, Stellenbosch University, Tygerberg, South Africa. annekeh@sun.ac.za
Insights
The incidence of disseminated bacille Calmette-Guérin (BCG) disease in HIV-infected infants is significantly higher than previously thought. This highlights an urgent need for better tuberculosis prevention strategies for these vulnerable infants.
Area of Science:
- Pediatric Infectious Diseases
- Immunization and Public Health
- HIV/AIDS Research
Background:
- Bacille Calmette-Guérin (BCG) vaccination is a global standard for tuberculosis prevention.
- HIV infection in infants significantly increases susceptibility to opportunistic infections.
- High burdens of both HIV and tuberculosis necessitate careful consideration of vaccination strategies in affected populations.
Purpose of the Study:
- To determine the population-based incidence of disseminated BCG disease in HIV-infected infants.
- To assess this risk in a setting with high HIV and tuberculosis prevalence.
- To inform public health decisions regarding BCG vaccination in vulnerable infant populations.
Main Methods:
- Prospective, multicentre surveillance data was used to identify cases of disseminated BCG disease in HIV-infected infants (aged ≤1 year) between 2004-2006.
- Population-based estimates of live births, maternal HIV prevalence, vertical transmission rates, and BCG vaccination rates were used to calculate the denominator.
- Incidence rates were calculated per 100,000 BCG-vaccinated, HIV-infected infants.
Main Results:
- The estimated incidence of disseminated BCG disease was substantially high, with pooled incidence at 992 per 100,000 infants over the study period.
- Specific incidences per 100,000 were 778 in 2004, 1300 in 2005, and 1013 in 2006.
- These findings suggest a considerably higher risk than previously estimated, potentially underestimated.
Conclusions:
- The risk of disseminated BCG disease in HIV-infected infants is considerably higher than previously recognized.
- Urgent data on the risk-benefit ratio of BCG vaccination in HIV-infected infants is needed.
- Development of safe and effective tuberculosis prevention strategies for HIV-infected infants is critical.
Objective:
To determine the population-based incidence of disseminated bacille Calmette-Guérin (BCG) disease in HIV-infected infants (aged
Methods:
The numerator, or number of new cases of disseminated BCG disease, was derived from multicentre surveillance data collected prospectively on infants with a confirmed HIV infection during 2004-2006. The denominator, or total number of HIV-infected infants who were BCG-vaccinated, was derived from population-based estimates of the number of live infants and from reported maternal HIV infection prevalence, vertical HIV transmission rates and BCG vaccination rates.
Findings:
The estimated incidences of disseminated BCG disease per 100 000 BCG-vaccinated, HIV-infected infants were as follows: 778 (95% confidence interval, CI: 361-1319) in 2004 (vertical HIV transmission rate: 10.4%); 1300 (95% CI: 587-2290) in 2005 (transmission rate: 6.1%); and 1013 (95% CI: 377-1895) in 2006 (transmission rate: 5.4%). The pooled incidence over the study period was 992 (95% CI: 567-1495) per 100 000.
Conclusion:
Multicentre surveillance data showed that the risk of disseminated BCG disease in HIV-infected infants is considerably higher than previously estimated, although likely to be under-estimated. There is an urgent need for data on the risk-benefit ratio of BCG vaccination in HIV-infected infants to inform decision-making in settings where HIV infection and tuberculosis burdens are high. Safe and effective tuberculosis prevention strategies are needed for HIV-infected infants.
Related Concept Videos
Cryptococcal Meningitis
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Cytomegalovirus Disease
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Rocky Mountain Spotted Fever
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

